# FDA Inspection 1178619 - BioLife Plasma Services LP - July 16, 2022

Source: https://www.keypedia.com/records/fda_inspections/biolife-plasma-services-lp/d569f0dc-424e-4ce3-be71-4e5990cf84ff
Source feed: FDA_Inspections

> FDA Inspection 1178619 for BioLife Plasma Services LP on July 16, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1178619
- Company Name: BioLife Plasma Services LP
- Inspection Date: 2022-07-16
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1178619 - 2022-07-16](https://www.keypedia.com/records/fda_inspections/biolife-plasma-services-lp/e245571b-ee0c-4ed6-aa37-c8f384408fc7)

Company: https://www.keypedia.com/companies/biolife-plasma-services-lp/4c0acbb7-8179-4221-bc40-d1a5aef1c747

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d